Brad Treeby
Co-founder & CEO, NeuroHarmonics
Brad Treeby is listed as Co-founder & CEO, NeuroHarmonics. Brad spoke at Slush 2026 in November 2026. Brad is scheduled to speak at Slush 2026 on 19 November 2026.
Compiled from published conference agendas; not yet confirmed by Brad. Is this you? Claim this profile.
About
Bradley Treeby is Founder & CEO of NeuroHarmonics, and believes the brain should be as reachable as any other organ, without an incision. Previously Professor of Biomedical Ultrasound at UCL, he developed ultrasound-brain interfaces, designed novel transducer arrays, built the open-source toolbox k-Wave, and led the first human studies targeting deep brain structures with millimetre precision, no surgery required. He left academia in late 2024 to found NeuroHarmonics with engineers and neuroscientists from leading institutions. Reaching a specific brain circuit today means surgery or systemic drugs. NeuroHarmonics offers the alternative: focused ultrasound that modulates any brain target non-invasively, starting with treatment-resistant conditions and extending to a mind-machine interface.
Upcoming
Slush 2026 18 November 2026 – 19 November 2026
- Clinical Operations Speaker · 19 November 2026
- Clinical Operations pitch 4 Speaker · 19 November 2026
- Therapeutics & Diagnostics Speaker · 19 November 2026
Sessions at 1 conference
Slush 2026 18 November 2026 – 19 November 2026
Announced as a speaker.
Spoke alongside
People who have shared a session with Brad at events on B2DB.
- David Hardwicke Co-founder & Director, Head of BD · Aerska 1 shared session
- Diane-Laure Pagés Co-founder & COO · Orakl Oncology 1 shared session
- Dr. Sonia Szamocki Founder & CEO · 01Health 1 shared session
- Federico Buersgens Co-founder & CEO · Amplifold 1 shared session
- Rachel Finegold Founder & CEO · Frontier Health 1 shared session
- Sami Marttinen Co-founder & CEO · Treat 1 shared session
- Simon Romanski Co-founder & CEO · Atlas.bio 1 shared session